IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3016% above fair value
$257.84+0.24 (+0.09%)
Close on Nov 18, 2026Market cap $42.49BP/E 31.3Yield –
Iqvia operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Iqvia's operating cash flow for the twelve months ending Sep 30, 2026 was $2.74B, down 2.4% year over year. For fiscal 2025 it was $2.65B, down 2.3% from the year before. Over ten years it grew 18.7% a year on average. The highest annual figure on record is $2.94B in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.65B | -2.3% |
| FY2024 | Dec 31, 2024 | $2.72B | +26.4% |
| FY2023 | Dec 31, 2023 | $2.15B | -4.9% |
| FY2022 | Dec 31, 2022 | $2.26B | -23.2% |
| FY2021 | Dec 31, 2021 | $2.94B | +50.2% |
| FY2020 | Dec 31, 2020 | $1.96B | +38.2% |
| FY2019 | Dec 31, 2019 | $1.42B | +13.0% |
| FY2018 | Dec 31, 2018 | $1.25B | +29.3% |
| FY2017 | Dec 31, 2017 | $970.00M | +12.8% |
| FY2016 | Dec 31, 2016 | $860.00M | +80.7% |
| FY2015 | Dec 31, 2015 | $476.00M | +9.9% |
| FY2014 | Dec 31, 2014 | $433.00M | +10.1% |
| FY2013 | Dec 31, 2013 | $393.37M | +17.2% |
| FY2012 | Dec 31, 2012 | $335.70M | +108.6% |
| FY2011 | Dec 31, 2011 | $160.95M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $825.00M | -9.1% |
| Q2 FY2026 | Jun 30, 2026 | $558.00M | +26.0% |
| Q1 FY2026 | Mar 31, 2026 | $618.00M | +8.8% |
| Q4 FY2025 | Dec 31, 2025 | $735.00M | -16.9% |
| Q3 FY2025 | Sep 30, 2025 | $908.00M | +25.9% |
| Q2 FY2025 | Jun 30, 2025 | $443.00M | -24.7% |
| Q1 FY2025 | Mar 31, 2025 | $568.00M | +8.8% |
| Q4 FY2024 | Dec 31, 2024 | $885.00M | +18.5% |
| Q3 FY2024 | Sep 30, 2024 | $721.00M | +23.7% |
| Q2 FY2024 | Jun 30, 2024 | $588.00M | +46.3% |
| Q1 FY2024 | Mar 31, 2024 | $522.00M | +25.2% |
| Q4 FY2023 | Dec 31, 2023 | $747.00M | +33.4% |
| Q3 FY2023 | Sep 30, 2023 | $583.00M | -32.4% |
| Q2 FY2023 | Jun 30, 2023 | $402.00M | +22.2% |
| Q1 FY2023 | Mar 31, 2023 | $417.00M | -17.9% |
| Q4 FY2022 | Dec 31, 2022 | $560.00M | -19.1% |
| Q3 FY2022 | Sep 30, 2022 | $863.00M | +2.3% |
| Q2 FY2022 | Jun 30, 2022 | $329.00M | -39.0% |
| Q1 FY2022 | Mar 31, 2022 | $508.00M | -41.4% |
| Q4 FY2021 | Dec 31, 2021 | $692.00M | -7.7% |
| Q3 FY2021 | Sep 30, 2021 | $844.00M | +47.0% |
| Q2 FY2021 | Jun 30, 2021 | $539.00M | +14.2% |
| Q1 FY2021 | Mar 31, 2021 | $867.00M | +431.9% |
| Q4 FY2020 | Dec 31, 2020 | $750.00M | +28.6% |
| Q3 FY2020 | Sep 30, 2020 | $574.00M | +73.9% |
| Q2 FY2020 | Jun 30, 2020 | $472.00M | +20.7% |
| Q1 FY2020 | Mar 31, 2020 | $163.00M | +44.2% |
| Q4 FY2019 | Dec 31, 2019 | $583.00M | +39.8% |
| Q3 FY2019 | Sep 30, 2019 | $330.00M | -4.1% |
| Q2 FY2019 | Jun 30, 2019 | $391.00M | +25.7% |
| Q1 FY2019 | Mar 31, 2019 | $113.00M | -37.9% |
| Q4 FY2018 | Dec 31, 2018 | $417.00M | +79.0% |
| Q3 FY2018 | Sep 30, 2018 | $344.00M | -21.1% |
| Q2 FY2018 | Jun 30, 2018 | $311.00M | +26.9% |
| Q1 FY2018 | Mar 31, 2018 | $182.00M | +225.0% |
| Q4 FY2017 | Dec 31, 2017 | $233.00M | -47.9% |
| Q3 FY2017 | Sep 30, 2017 | $436.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $245.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $56.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $447.00M | – |
See a number that looks wrong?